US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Articles published by Shift Bioscience

News headline image
Shift Bioscience Publication Increases Confidence in AI Virtual Cells for Novel Target Discovery
From Shift Bioscience
Via Business Wire
News headline image
Shift Bioscience Publishes Improved Metric Calibration Framework for Robust Genetic Perturbation Modeling Using AI Virtual Cells
From Shift Bioscience
Via Business Wire
News headline image
Shift Bioscience Appoints Lord David Prior and Sir Tony Kouzarides to Support Long-Term Strategy for Cell Rejuvenation Therapeutics
From Shift Bioscience
Via Business Wire
News headline image
Shift Bioscience Announces Key Appointments to Advance Rejuvenation Therapeutics Pipeline
From Shift Bioscience
Via Business Wire
News headline image
Shift Bioscience Establishes North American Facilities to Expand Capabilities of AI-Powered Virtual Cell Technology
From Shift Bioscience
Via Business Wire
News headline image
Shift Bioscience Raises $16M to Advance Cell Simulation AI Platform
From Shift Bioscience
Via Business Wire